Boston Scientific | BSX - Debt

Stock Price
77.64
Daily Change
2.14 2.83%
Monthly
-20.61%
Yearly
-26.07%
Q1 Forecast
90.65

Boston Scientific reported $12.05B in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
Abbott USD 12.94B 496M Sep/2025
AtriCure USD 77.25M 15.39M Jun/2025
Avanos Medical USD 137.3M 29.9M Jun/2025
Baxter International USD 9.73B 584M Jun/2025
Becton, Dickinson and Co. USD 19.18B 160M Sep/2025
Boston Scientific USD 12.05B 19M Sep/2025
CONMED USD 853.75M 28.07M Sep/2025
Cooper Companies USD 2.48B 285.1M Jun/2025
Danaher USD 18.42B 1.56B Dec/2025
Dexcom USD 2.45B 132.5M Sep/2025
Edwards Lifesciences USD 702.6M 3.2M Jun/2025
Globus Medical USD 121.1M 120.63M Jun/2025
Hologic USD 2.63B 104.3M Sep/2025
Illumina USD 2.58B 22M Sep/2025
Insulet USD 1.4B 295.7M Jun/2025
Integra LifeSciences USD 2.01B 170.48M Jun/2025
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 45.8B 4.97B Sep/2025
Masimo USD 642.2M 299.4M Jun/2025
Medtronic USD 28.61B 93M Jun/2025
Merit Medical Systems USD 820.55M 89.88M Jun/2025
Stryker USD 14.86B 1.74B Dec/2025
Tandem Diabetes Care USD 449.01M 94.67M Jun/2025
Teleflex USD 2B 180.08M Jun/2025
Zimmer Biomet Holdings USD 8.11B 540.1M Sep/2025